Evaluation of tumour markers in patients with burning mouth syndrome

Oral Oncology

Volumn 39, Issue 7, 2003, Pages 742-744

  Vucicevic Boras V ^a   Lukinac, L J ^b   Cekic Arambasin A ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; BURNING MOUTH SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EVALUATION; HUMAN; IMMUNORADIOMETRIC ASSAY; LETTER; MALIGNANT NEOPLASTIC DISEASE; MOUTH EXAMINATION; MOUTH MUCOSA; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

EID: 0043204605     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(02)00146-X     Document Type: Letter

References (21)

1. Grushka M. Burning mouth. a review and update Ontario Dent. 60:1983;56-61.
2. Zegarelli D.J. Burning mouth syndrome. an analysis of 57 patients Oral Surg Oral Med Oral Pathol. 58:1984;34-38.
3. Bergdahl J., Anneroth G., Anneroth I. Clinical study of patients with burning mouth. Scand J Dent Res. 102:1994;299-305.
4. Glass B.J. Drug-induced xerostomia as a cause of glossodynia. Ear Nose Throat. 68:1989;776-781.
5. Main D.M.G., Basker R.M. Patients complaining of a burning mouth. Further experience in clinical assesment and managment. Br Dent J. 154:1983;206-211.
6. Van Loon L.A.J., Bos J.D., Davidson C.L. Clinical evaluation of 56 patients reffered with symptoms tentatively related to allergic contact stomatitis. Oral Surg Oral Med Oral Pathol. 74:1992;572-575.
7. Paterson A.J., Lamb A.B., Clifford T.J., Lamey P.J. Burning mouth syndrome. the relationship between the HAD scale and parafunctional habits J Oral Pathol Med. 24:1995;289-292.
8. Basker R.M., Sturdee D.W., Davenport J.C. Patients with burning mouth. A clinical investigation of causative factors including the climacteric and diabetes. Br Dent J. 145:1978;9-16.
9. Gorsky M., Silvermann S., Chinn H. Burning mouth syndrome. a review of 98 cases J Oral Med. 42:1987;7-9.
10. Brown R.S., Krakow A.M., Douglas T., Choksi S.K. Scalded mouth syndrome-caused by angiotensin converting enzyme inhibitors. Oral Surg Oral Med Oral Pathol. 83:1997;665-667.
11. Bogduk N. An anatomical basis for neck-tongue syndrome. J Neurology, Neurosurgery, Psychiatry. 44:1981;202-208.
12. Wambach G., Engelskirchen R., Saborowski F. Therapieresistentes Zungenbrennen als Fruhsymptom eines kleinzelligen Bronchialkarzinoms. Med Welt. 30:1979;993-995.
13. Ship J.A., Grushka M., Lipton J.A., Mott A.E., Sessle J., Diorne R.A. Burning mouth syndrome. an update J Am Dent Assoc. 126:1995;843-852.
14. Ferguson J.W., Burton J.F. Clinical presentation of acoustic nerve neuroma in the oral and maxillofacial region. Oral Surg Oral Med Oral Pathol. 69:1990;672-675.
15. Lamb A.B., Lamey P.J., Reeve P.E. Burning mouth syndrome. psychological aspects Br Dent J. 165:1988;256.
16. Thorstensson B., Hugoson A. Prevalence of some oral complaints and their relation to oral health variables in adult Swedish population. Acta Odontol Scand. 54:1996;257-262.
17. Forman R., Settle R.G., Brightman V., Feldman R. The prevalence by history of burning mouth symptoms among veterans. J Dent Res. 68:1989;278.
18. Markman L. Basic cancer medicine. 1997;WB Saunders, Philadelphia.
19. Ivancevic D., Dodig D., Kusic Z. Kliniaka nuklearna medicina. 1999;Medicinska naklada, Zagreb.
20. Ward M.A. Tumour markers, their rational use in cancer management. The immunoassay Kit Directory, series A, Volume 1, Part 3 (proteins and tumour markers). 1992;Kluwer Academic Publishers. (ISSN 0926-2067).
21. Mauri L. Tumour markers. Basic cancer medicine. 1997;WB Saunders, Philadelphia.